Kaplan-Meier survival curves of admissions and mortality in patients with dementia with Lewy bodies, by medication use.

Kaplan-Meier survival curves of admissions and mortality in patients with dementia with Lewy bodies, by medication use.

<p>Panels A, B and C present the recurrent events. <i>P</i> values are calculated from the log-rank test. AChEIs, acetylcholinesterase inhibitors.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Shanquan Chen (3417512) (author)
مؤلفون آخرون:	Annabel C. Price (14227706) (author), Rudolf N. Cardinal (9693656) (author), Sinéad Moylett (14227709) (author), Anne D. Kershenbaum (14227712) (author), James Fitzgerald (12569602) (author), Christoph Mueller (224259) (author), Robert Stewart (34430) (author), John T. O’Brien (4182826) (author)
منشور في:	2022
الموضوعات:	Medicine Neuroscience Biotechnology Cancer Science Policy Mental Health sensitivity analyses confirmed selection bias resulting possible confounds cannot nonrandom prescription behaviour might improve outcomes linear regression models including acetylcholinesterase inhibitors global health performance cox proportional hazard alzheimer &# 8217 >&# 967 ;</ 31 december 2019 symptomatically benefit people significantly shorter periods significant additional associations never used acheis mental health disorders investigated whether acheis adjusted hazard ratio 86 million ), outcomes included admission never took acheis 100 took acheis unplanned hospital admission retrospective cohort study 2 </ sup 1 january 2005 electronic clinical records reduced hospital admissions significantly lower risk antidementia medication use xlink "> dementia patients taking acheis xlink "> hospital admissions 273 took taking acheis started acheis significant differences shorter duration physical disorders linked records decreased risk antidementia drugs >< sup clinical trials clinical practice respectively ), − 3 treat design socioeconomic status sociodemographic factors planned admissions physical comorbidity people diagnosed p </ marital status main limitation lewy bodies fully controlled eligible patients controls ). common cause cognitive status baseline characters antidepressant use anticholinergic burden adjusted hr ad ). [− 26 [− 24 981 days 896 days 85 ], 592 patients 09 ], 05 ). 004 days 003 ).
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!